放射性药物治疗单时间点剂量学的可行性分析
本研究分析两种单时间点(STP)剂量学方法,基于有效半衰期分布评估多种放射性药物在不同注射后扫描时间的剂量误差。结果显示STP框架对177Lu-DOTATATE及不同药物的肾脏剂量学有前景(误差<30%),但对177Lu-PSMA的骨髓和肿瘤等准确性受损。结论认为简化STP剂量学可能损害剂量估计准确性,临床简化个体化剂量学仍具挑战。
要点
- STP剂量学对177Lu-DOTATATE及不同药物肾脏剂量学误差<30%,有应用前景。
- 177Lu-PSMA骨髓和肿瘤等STP准确性受损,需谨慎使用简化方法。
- 177Lu-DOTATATE最佳SPECT扫描时间约72 h p.i.,177Lu-PSMA为48 h p.i.。
核心结论
- 简化STP剂量学方法可能损害剂量估计准确性,但177Lu-DOTATATE和不同药物的肾脏剂量学例外。
- 临床简化个体化剂量学仍具挑战性,基于结果提出改进建议。
研究设计与样本
- 分析两种STP剂量学方法,基于有效半衰期分布评估多种放射性药物在神经内分泌肿瘤和前列腺癌中的剂量误差。
主要发现
- 有效半衰期分布更符合对数正态分布而非高斯分布。
- STP框架对177Lu-DOTATATE及不同药物肾脏剂量学误差<30%,有前景。
- 对177Lu-PSMA的骨髓和肿瘤等STP准确性受损。
关键数值与推荐
- 177Lu-DOTATATE最佳SPECT扫描时间约72 h p.i.。
- 177Lu-PSMA最佳SPECT扫描时间48 h p.i.。
- 肾脏剂量学STP误差<30%。
临床怎么用
- 对177Lu-DOTATATE和肾脏剂量学可考虑STP简化方案。
- 对177Lu-PSMA骨髓和肿瘤剂量学应谨慎使用STP方法。
局限性
- STP剂量学独立验证有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Because of challenges in performing routine personalized dosimetry in radiopharmaceutical therapies, interest in single-time-point (STP) dosimetry, particularly using only a single SPECT scan, is on the rise. Meanwhile, there are questions about the reliability of STP dosimetry, with limited independent validations. In the present work, we analyzed 2 STP dosimetry methods and evaluated dose errors for several radiopharmaceuticals based on effective half-life distributions. Methods: We first challenged the common assumption that radiopharmaceutical effective half-lives across the population are gaussian-distributed (i.e., follow a normal distribution). Then, dose accuracy was estimated using 2 STP dosimetry methods for a wide range of potential post injection (p.i.) scan time points for different radiopharmaceuticals applied to neuroendocrine tumors and prostate cancer. The accuracy and limitations of each of the STP methods were discussed. Results: A lognormal distribution was more appropriate for capturing effective half-life distributions. The STP framework was promising for dosimetry of 177Lu-DOTATATE and for kidney dosimetry of different radiopharmaceuticals (errors < 30%). Meanwhile, for some radiopharmaceuticals, STP accuracy was compromised (e.g., in bone marrow and tumors for 177-labeled prostate-specific membrane antigen [PSMA])). The optimal SPECT scanning time for 177Lu-DOTATATE was approximately 72 h p.i., whereas 48 h p.i. was better for 177Lu-PSMA. Conclusion: Simplified STP dosimetry methods may compromise the accuracy of dose estimates, with some exceptions, such as for 177Lu-DOTATATE and for kidney dosimetry in different radiopharmaceuticals. Simplified personalized dosimetry in the clinic continues to be challenging. On the basis of our results, we make suggestions and recommendations for improved personalized dosimetry using simplified imaging schemes.
引用
- Hou X, Brosch J, Uribe C, et al. Feasibility of Single-Time-Point Dosimetry for Radiopharmaceutical Therapies. J Nucl Med. 2020. PMID: 33127625. doi:10.2967/jnumed.120.254656
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。